Research Interest: Drug Discovery and Development from Plant Sources. Isolation and Characterization of Bioactive Molecules from High Altitude Medicinal and Aromatic Plants Using Different Separation Techniques Like TLC, Column Chromatography, Preparative TLC, HPLC, HPTLC, LC-MS, GC-FID And GC-MS. Characterization of the Isolated Molecules from the Plants Using Different Spectroscopic Techniques Like 1H NMR, 13C NMR, 2D Techniques, Mass Spectrometry, IR, X-Ray, UV- Visible Etc. Structural Modifications of these Molecules to Value Add their Biological Properties. Chemical Characterization Using Capillary GC-FID and GC-MS Analytical Techniques and Bioevaluation of Essential Oils, Oleoresins and Other Aroma Mixtures Isolated from Aromatic Plants with Main Thrust on Unexplored Flora of the Kashmir Valley

Research Interest: Haematology Including Body Fluids, Clinical Biochemistry, Blood Bank, Clinical Microbiology, Cyto- Histopathology

Research Interest: Bladder Cancer, Prostate Cancer, Renal Cancer, Urolithiasis And Uro-Gynaecology.

Research Interest: The Physiological Role Of PSA In Prostate Tissue Microenvironment, In Prostate Tumor Growth And Progression, And In Prostate Cancer Metastasis Is Not Known. Attenuation Of PSA Levels With Age, Disease Progression, Or During Androgen Deprivation Therapy, However, Removes This Important Regulator Of Angiogenesis, And By Extension Results In Tumor Progression. Re-Introduction Of Human PSA Into The Prostate Tissue Microenvironment May Suppress Tumor Angiogenesis Through Either The Inhibition Of Expression Of Pro-Angiogenic Genes Or Induction Of Expression Of Anti-Angiogenic Genes, Or Via Inhibition Of Signaling Mechanisms Associated With Angiogenesis That Are Independent Of Gene Transcription. Validation Of An Anti-Angiogenic Effect Of PSA On The Human Tissue Vasculature In A Pre-Clinical Model Of Primary Xenografts Of Human Prostate And Prostate Cancer Tissue Will Provide Compelling Evidence That PSA Has Therapeutic Potential Against Prostate Cancer.

Research Interest: Her Major Scientific Interests Include Cancer Biology And Treatment, With Particular Emphasis On Sphingolipid Signalling In Cancer.

Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development

Research Interest: Toxicology And Pharmaceutical Applications Of Decavanadate; Ii) Muscle Contraction And Regulation; Iii) Insulin Mimetic Compounds.

Research Interest: Oncology,including basic and clinical

Research Interest: The Synthesis and Evaluation of New Molecules for Anticancer Activity; QSAR and Drug Design; HPLC and Chiral Separation

Research Interest: Cancer Immunotherapies  Therapeutic Cancer Vaccines, Genitourinary Malignancies

Research Interest: Shinq-Jen Wu, Da-Yeh University, Chang-Hwa, Taiwan

Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies

Research Interest:  Highly Interested in Modern, Advanced Radiotherapy Techniques such as IMRT IGRT, Adaptive Radiotherapy and How to Use Them to Improve the Treatment Outcome of Cancer Patients

Research Interest: Discovery of Novel Antiviral, Anticancer and Neurodegenerative Diseases-Related Agents Based on The Rational Drug Design Approaches.